药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Lorcaserin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lorcaserin.
Potassium cation
Fluspirilene
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fluspirilene.
Potassium cation
Flunarizine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Flunarizine.
Potassium cation
Amineptine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amineptine.
Potassium cation
Rapacuronium
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rapacuronium.
Potassium cation
Methaqualone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methaqualone.
Potassium cation
Lysergic acid diethylamide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lysergic acid diethylamide.
Potassium cation
Urethane
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Urethane.
Potassium cation
Nomifensine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nomifensine.
Potassium cation
Nialamide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nialamide.
Potassium cation
Methapyrilene
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methapyrilene.
Potassium cation
Iproniazid
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iproniazid.
Potassium cation
Aniracetam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Aniracetam.
Potassium cation
Phenethylamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenethylamine.
Potassium cation
Valpromide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Valpromide.
Potassium cation
Clorgiline
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clorgiline.
Potassium cation
Phencyclidine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phencyclidine.
Potassium cation
Oxitriptan
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxitriptan.
Potassium cation
Domoic Acid
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Domoic Acid.
Potassium cation
S-Ethylisothiourea
The risk or severity of adverse effects can be increased when Cannabidiol is combined with S-Ethylisothiourea.